EMROSI
Live / Applied — Statement of use — registration review complete (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 04 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98834968
- Mark type
- Stylized text
- Filed
- 04 Nov 2024
- Published for opposition
- 08 Jul 2025
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Medicated skin preparation for the treatment of rosacea; Medicated skin preparation for the treatment of erythema
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of skin conditions
Owner
- Journey Medical Corporation, Scottsdale, AZ, US
- Journey Medical Corporation, Scottsdale, AZ, US
Prosecution history
- 02 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Sept 2025 — USE AMENDMENT FILED
- 20 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 19 Sept 2025 — SOU EXTENSION 1 GRANTED
- 19 Sept 2025 — SOU EXTENSION 1 FILED
- 19 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Jun 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 29 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER